ApprovalTrail

Approval · Notice of Compliance 26178 · 2021

MELOXICAM: Notice of Compliance 26178

Issued June 30, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
26178
Date
June 30, 2021
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
Administrative: Licensing Agreement Between Two
Canadian reference product
MOBICOX

Products in this notice

BrandDINStatus today
MELOXICAM02353148Marketed
MELOXICAM02353156Marketed

Medicinal ingredients